Efficacy of Intrathecal Administration of Liposomal Amphotericin B in Cryptococcal Meningitis

NCT02686853 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2016-02-22

No results posted yet for this study

Summary

The main purpose of this study is to observe the clinical effect of intrathecal administration of liposomal amphotericin B in Cryptococcal Meningitis without Acquired Immune Deficiency Syndrome (AIDS).

Conditions

  • Cryptococcal Meningitis

Interventions

DRUG

Liposomal amphotericin B

Sponsors & Collaborators

  • Hui Bu

    lead OTHER

Principal Investigators

  • Hui Bu, MD · The Second Hospital of Hebei Medical University

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
14 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-01-31
Primary Completion
2018-01-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02686853 on ClinicalTrials.gov